Targeted disruption of gene function in Drosophila by RNA interference (RNA-i): A role for nautilus in embryonic somatic muscle formation

Leonie Misquitta1, Bruce M. Paterson2
1Laboratory of Biochemistry, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 USA
2Laboratory of Biochemistry, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.

Tóm tắt

The expression of the MyoD gene homolog, nautilus (nau), in the Drosophila embryo defines a subset of mesodermal cells known as the muscle “pioneer” or “founder” cells. These cells are thought to establish the future muscle pattern in each hemisegment. Founders appear to recruit fusion-competent mesodermal cells to establish a particular muscle fiber type. In support of this concept every somatic muscle in the embryo is associated with one or more nautilus -positive cells. However, because of the lack of known (isolated) nautilus mutations, no direct test of the founder cell hypothesis has been possible. We now have utilized toxin ablation and genetic interference by double-stranded RNA (RNA interference or RNA-i) to determine both the role of the nautilus -expressing cells and the nautilus gene, respectively, in embryonic muscle formation. In the absence of nautilus -expressing cells muscle formation is severely disrupted or absent. A similar phenotype is observed with the elimination of the nautilus gene product by genetic interference upon injection of nautilus double-stranded RNA. These results define a crucial role for nautilus in embryonic muscle formation. The application of RNA interference to a variety of known Drosophila mutations as controls gave phenotypes essentially indistinguishable from the original mutation. RNA-i provides a powerful approach for the targeted disruption of a given genetic function in Drosophila .

Từ khóa


Tài liệu tham khảo

10.1242/dev.121.7.1979

10.1242/dev.110.3.791

10.1038/301066a0

10.1006/dbio.1998.9009

10.1016/S0168-9525(00)89030-7

10.1016/S0070-2153(08)60244-6

10.1242/dev.121.11.3703

10.1242/dev.124.17.3253

10.1073/pnas.88.9.3782

10.1038/35888

10.1002/j.1460-2075.1988.tb03056.x

10.1101/gad.2.7.843

10.1101/gad.2.12a.1666

J A Kassis, C Desplan, D K Wright, P H O’Farrell Mol Cell Biol 9, 4304–4311 (1989).

10.1101/gad.4.12a.2098

10.1073/pnas.91.12.5662

V Pirrotta Biotechnology 10, 437–456 (1988).

10.1242/dev.118.2.401

10.1242/dev.125.11.2075

10.1242/dev.120.6.1631

10.1002/bies.950170306

10.1006/dbio.1996.8434

10.1126/science.7839146

10.1016/0092-8674(93)90610-3

10.1016/S0092-8674(00)81725-0